Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Aiforia launches new AI platform

Aiforia Technologies

Translation: Original published in Finnish on 12/18/2025 at 8:20 am EET.

Aiforia announced on Wednesday the launch of a new generation AI platform that utilizes Vision Transformer technology. The new technology promises to accelerate the development of AI models and improve their performance, supporting the expansion of the company's product portfolio. The news has no direct impact on our forecasts, but we view the increased efficiency in product development positively, as it partly mitigates risks related to the company's innovation capabilities after cost cuts and supports its long-term competitiveness.

The new Foundation Engine solution enhances model development

Aiforia announced on Wednesday that it is expanding its AI platform with a new solution called Foundation Engine, which is based on the Vision Transformer architecture. According to the company, the new solution combines so-called foundation models, pre-trained on extensive image datasets, with task-specific annotations made by pathologists. Aiforia highlights that the key benefits of the technology are the acceleration of AI model development and the improved generalizability of models to different image datasets. The new technology will be deployed in Aiforia's own product development and will also be integrated into the Aiforia Create development tool available to customers.

The company referred to the benefits of the expansion in its own product development earlier in the fall, so the launch does not come as a particular surprise or put pressure on forecast changes. In any case, the acceleration of model development supports the company's goals to improve its operational efficiency. Aiforia has recently focused on optimizing its cost structure and securing its path to profitability. In our view, more efficient product development through new technology mitigates the risks of cost savings to the company's innovation pace and supports the company's ability to maintain competitiveness in the long term. In addition to supporting the expansion of the product portfolio in the clinical segment, which is central to Aiforia's growth strategy, the technology also fundamentally strengthens Aiforia's product for its research customers who develop their own models on the Aiforia platform.

 

Login required

This content is only available for logged in users

Create account

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of fields such as oncology and neuroscience. Aiforia Technologies is headquartered in Finland.

Read more on company page

Key Estimate Figures19.11.2025

202425e26e
Revenue2.93.35.1
growth-%18.9 %16.4 %55.0 %
EBIT (adj.)-12.2-10.9-8.6
EBIT-% (adj.)-427.8 %-328.4 %-167.6 %
EPS (adj.)-0.41-0.39-0.28
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.

Forum discussions

Joensuun Kauppa ja Kone Oy’s visit was short. It’s no longer on the list.
yesterday
by TO
9
Insiders and the largest owners have mainly added shares, except for Citibank which sold about 200k and Tukiainen Tom 30k. Aiforia Aiforia -...
yesterday
by Jekkku
16
Unfortunately, I won’t make it. The idea was to go there in person, but work commitments got in the way. Today might see some fund report selling...
3/31/2026, 1:14 PM
by Puutaheinää
2
Is anyone here going to the annual general meeting on Thursday? Shareholders of Aiforia Technologies Plc are invited to the Annual General Meeting...
3/31/2026, 12:47 PM
by Jekkku
2
AI informed me that tenders are being sought in that area UK: Massive NHS-led consolidation of pathology services, creating large regional networks...
3/27/2026, 11:23 AM
by Jekkku
11
Aiforia is recruiting an executive leader for European sales. They really emphasize in bold that the person must be UK-based. What does Aiforia...
3/27/2026, 10:54 AM
by Puutaheinää
13
In a slightly different position in that digital pathology pipeline, but a small company like Aiforia, only with a valuation in the hundreds...
3/25/2026, 8:05 AM
by Puutaheinää
9
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.